Larson Financial Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $748 | Buy |
44
+14
| +47% | +$238 | ﹤0.01% | 2718 |
|
|
2025
Q1 | $586 | Hold |
30
| – | – | ﹤0.01% | 2510 |
|
|
2024
Q4 | $744 | Sell |
30
-43
| -59% | -$1.07K | ﹤0.01% | 2097 |
|
|
2024
Q3 | $1.79K | Buy |
73
+43
| +143% | +$1.05K | ﹤0.01% | 1862 |
|
|
2024
Q2 | $703 | Hold |
30
| – | – | ﹤0.01% | 1766 |
|
|
2024
Q1 | $991 | Buy |
30
+20
| +200% | +$661 | ﹤0.01% | 1446 |
|
|
2023
Q4 | $272 | Hold |
10
| – | – | ﹤0.01% | 1629 |
|
|
2023
Q3 | $241 | Hold |
10
| – | – | ﹤0.01% | 1622 |
|
|
2023
Q2 | $319 | Hold |
10
| – | – | ﹤0.01% | 1475 |
|
|
2023
Q1 | $306 | Hold |
10
| – | – | ﹤0.01% | 1443 |
|
|
2022
Q4 | $391 | Hold |
10
| – | – | ﹤0.01% | 1391 |
|
|
2022
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 1298 |
|
|
2022
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 1190 |
|
|
2022
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 951 |
|
|
2021
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 992 |
|
|
2021
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 808 |
|
|
2021
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 749 |
|
|
2021
Q1 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 744 |
|